# Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

> **NCT01468545** · — · COMPLETED · sponsor: **Bayer** · enrollment: 38 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **OTHER:** Iloprost (Ventavis inhaled, BAYQ6256)
- **OTHER:** Iloprost (Ventavis inhaled, BAYQ6256)

## Key facts

- **NCT ID:** NCT01468545
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-01
- **Final completion:** 2014-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01468545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01468545, "Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01468545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*